Statistics
Publications
6
Citations
517
H-Index
6
Active since
2017
Helen Clare Dearden is an author at The University of Sydney specializing in cancer immunotherapy, oncology, and combination immunotherapy.
Publications per year
2017–2025
6
6
Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy
Helen Clare Dearden, Lewis Au, Daniel Wang et al. · European Journal of Cancer · 2021 · 30 citations
1–5 of 6